{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:57:44Z","timestamp":1763765864908},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10165-011-0481-0","type":"journal-article","created":{"date-parts":[[2011,6,11]],"date-time":"2011-06-11T13:02:28Z","timestamp":1307797348000},"page":"109-115","source":"Crossref","is-referenced-by-count":19,"title":["Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis"],"prefix":"10.1093","volume":"22","author":[{"given":"Tomoyuki","family":"Imagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumpei","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Miyamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syuji","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Nerome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamitsu","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,6,12]]},"reference":[{"key":"481_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, International League of Associations for Rheumatology, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"481_CR2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"EH Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, et al. Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med. 1992;326:1043\u20139.","journal-title":"N Engl J Med"},{"key":"481_CR3","first-page":"113","volume":"13","author":"A Reiff","year":"1995","unstructured":"Reiff A, Shaham B, Wood BP, Bernstein BH, Stanley P, Szer IS. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1995;13:113\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"481_CR4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","volume":"43","author":"P Woo","year":"2000","unstructured":"Woo P, Southwood TR, Prieur AM, Dore CJ, Grainger J, David J. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. 2000;43:1849\u201357.","journal-title":"Arthritis Rheum"},{"key":"481_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1529-0131(199803)41:3<381::AID-ART2>3.0.CO;2-3","volume":"41","author":"CA Wallace","year":"1998","unstructured":"Wallace CA. The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum. 1998;41:381\u201391.","journal-title":"Arthritis Rheum"},{"key":"481_CR6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.1780391013","volume":"39","author":"AA Grom","year":"1996","unstructured":"Grom AA, Murray KJ, Luyrink L, Emery H, Passo MH, Glass DN, et al. Patterns of expression of tumor necrosis factor \u03b1, tumor necrosis factor \u03b2, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondyloarthropathy. Arthritis Rheum. 1996;39:1703\u201310.","journal-title":"Arthritis Rheum"},{"key":"481_CR7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","volume":"34","author":"F Benedetti De","year":"1991","unstructured":"De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 1991;34:1158\u201363.","journal-title":"Arthritis Rheum"},{"key":"481_CR8","first-page":"493","volume":"10","author":"F Benedetti De","year":"1992","unstructured":"De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol. 1992;10:493\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"481_CR9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Pediatric Rheumatology Collaborative Study Group, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med. 2000;342:763\u20139.","journal-title":"N Engl J Med"},{"key":"481_CR10","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","volume":"58","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008;58:1496\u2013504.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"481_CR11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum. 2003;48(4):1093\u2013101.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"481_CR12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10165-008-0125-1","volume":"19","author":"N Nishimoto","year":"2009","unstructured":"Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Mod Rheumatol. 2009;19(1):12\u20139.","journal-title":"Mod Rheumatol"},{"key":"481_CR13","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106:2627\u201332.","journal-title":"Blood"},{"key":"481_CR14","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.10620","volume":"46","author":"M Iwamoto","year":"2002","unstructured":"Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still\u2019s disease. Arthritis Rheum. 2002;46:3388\u20139.","journal-title":"Arthritis Rheum"},{"key":"481_CR15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998\u20131006.","journal-title":"Lancet"},{"key":"481_CR16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202\u20139.","journal-title":"Arthritis Rheum"},{"key":"481_CR17","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","volume":"49","author":"DM Heijde van der","year":"1990","unstructured":"van der Heijde DM, van \u2019t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990;49:916\u201320.","journal-title":"Ann Rheum Dis"},{"key":"481_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"MLL Prevoo","year":"1995","unstructured":"Prevoo MLL, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PL, et al. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u20138.","journal-title":"Arthritis Rheum"},{"key":"481_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM Gestel van","year":"1996","unstructured":"van Gestel AM, Prevoo MLL, van\u2019t Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PL, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism criteria. Arthritis Rheum. 1996;39:34\u201340.","journal-title":"Arthritis Rheum"},{"key":"481_CR20","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","volume":"112","author":"N Nishimoto","year":"2008","unstructured":"Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112:3959\u201364.","journal-title":"Blood"},{"key":"481_CR21","first-page":"5","volume":"37","author":"P Stastny","year":"1993","unstructured":"Stastny P, Fernandez-Vina M, Cerna M, Havelka S, Ivaskova E, Vavrincova P. Sequences of HLA alleles associated with arthritis in adults and children. J Rheumatol Suppl. 1993;37:5\u20138.","journal-title":"J Rheumatol Suppl"},{"key":"481_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00307736","volume":"13","author":"H Okubo","year":"1993","unstructured":"Okubo H, Itou K, Tanaka S, Watanabe N, Kashiwagi N, Obata F, et al. Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing. Rheumatol Int. 1993;13:65\u20139.","journal-title":"Rheumatol Int"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0481-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:22Z","timestamp":1646843122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0481-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0481-0","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,12]]}}}